バイオリアクターの市場規模、シェア、予測、動向分析：タイプ別、バイオプロセス別、有用性別、スケール別、細胞タイプ別、用途別、ユーザー別 - 2031年までの世界予測

世界のバイオリアクター市場は、2024年から2031年までのCAGRが10.1%で、2031年までに399億6,000万米ドルに達すると予測されます。

本レポートでは、包括的な一次調査および二次調査と市場シナリオの詳細な分析に基づき、バイオリアクター市場の主要促進要因・市場抑制要因・機会・課題に関する洞察を提供します。同市場の成長は、バイオ医薬品工場の拡大、医薬品セクターの成長、医薬品研究開発費の増加、バイオシミラーの採用増加、製薬・バイオテクノロジーセクターにおける使い捨て技術の採用拡大が牽引しています。しかし、バイオ医薬品の開発・製造プロセスは複雑であり、バイオ医薬品製造に必要な資本要件も高いことから、市場の成長は抑制されています。

さらに、バイオリアクター技術の進歩や、個別化医薬品や細胞・遺伝子治療の採用拡大により、市場成長の機会が生まれると期待されています。しかし、シングルユース・バイオリアクターを使用するバイオ製造プロセスにおける抽出物および浸出物（E&L）に関連するリスク、バイオ医薬品プロセスのスケールアップにおける限界、シングルユース・バイオリアクターの設計を標準化する必要性、シングルユース・バイオリアクターの廃棄に関連する環境上の懸念は、市場の成長に影響を与える課題の一部です。

製品別では、2024年には連続攪拌タンク型バイオリアクターセグメントがバイオリアクター市場の31%という最大シェアを占めると予想されています。このセグメントの市場シェアが大きいのは、連続式攪拌タンク型バイオリアクターの技術的進歩と、他のバイオリアクターに比べて伝熱特性に優れているため高濃度の反応物を扱えることに起因しています。さらに、市場のプレーヤーは、既存のフローシステムとシームレスに統合するためにバイオリアクターの設計を強化しています。例えば、2024年10月にVapourtec Ltd.（英国）は、連続プロセス合成用に設計された連続攪拌タンク型バイオリアクターを発売しました。

バイオプロセスに基づくと、2024年にはバッチ/フェッドバッチセグメントがバイオリアクター市場で最大のシェアを占めると予想されます。このセグメントの市場シェアが大きいのは、高い生産性、バイオプロセス管理の簡素化、汚染リスクの低減など、バッチ/フェドバッチ・バイオプロセシングの利点によるものです。バッチ処理の持続時間は迅速な実験に理想的であり、上流工程を加速させ、全体的な生産性を向上させます。

細胞タイプ別では、2024年には哺乳類細胞セグメントがバイオリアクター市場で最大のシェアを占めると予想されています。このセグメントの市場シェアが大きいのは、モノクローナル抗体や治療用タンパク質のような複雑な生体分子の商業的・研究的バイオ生産への注目が高まっているためです。さらに、哺乳類細胞を含む臨床研究の成長により、シングルユース・バイオリアクターの採用が広がっています。

使い勝手に基づくと、2024年には再利用型バイオリアクターセグメントがバイオリアクター市場でより大きなシェアを占めると予想されます。このセグメントの市場シェアが大きいのは、大規模製造の増加に起因しており、再利用可能なバイオリアクターは、そのコスト効率と大量生産への対応に適していることから、採用が増加しています。さらに、廃棄物処理に関連する高いコストと規制上の制約が、再利用可能なバイオリアクターの採用増加を後押ししています。

規模別では、パイロットスケールバイオリアクター（10L～200L）分野が市場で最も高いCAGRを記録する予定です。パイロットスケールバイオリアクターは、容量10Lから200Lのシステムであり、複数のバリエーションやカスタマイズが可能です。パイロットスケール・バイオリアクターは、食品、製薬、化粧品産業で幅広く応用されており、主に本格的な生産前のバイオプロセスの試験や改良に使用されます。商業的バイオ生産に対する需要の増加は、パイロットスケールバイオプロセシングの採用を促進します。なぜなら、これらのバイオリアクターは、効率性、拡張性、工業的環境に近い条件下での性能を評価する上で極めて重要だからです。

自動化に基づくと、2024年には自動化バイオリアクターセグメントが市場でより大きなシェアを占めると予想されます。このセグメントの大きな市場シェアは、プロセスの品質向上、エラーの減少、プロセス制御の最適化、コスト削減など、自動バイオリアクターが提供するメリットに起因しています。自動バイオリアクターは、リアルタイムのモニタリングと豊富なデータによる品質管理を通じて、品質と生産性の向上に貢献します。手順や実験を合理化し、プロセスの逸脱を迅速に検出します。

用途別では、2024年には商業生産分野がバイオリアクター市場で大きなシェアを占めると予想されています。商業生産には、モノクローナル抗体（mAb）生産、細胞・遺伝子治療生産、ワクチン製造、血漿分画、組換えタンパク質生産が含まれます。このセグメントの市場シェアが大きいのは、バイオ医薬品の採用が拡大していること、バイオシミラーの採用促進を目的とした規制改革が好意的であること、遺伝子治療開発への投資が増加していることに起因しています。

エンドユーザー別に見ると、2024年にはバイオ医薬品メーカー分野が最大シェアを占めると予想されます。バイオ医薬品メーカーは、バイオ医薬品に対する需要の増加、慢性疾患の罹患率の増加、製薬・バイオテクノロジー企業による研究開発費の増加、慢性疾患・希少疾患に対する生物製剤の最近の上市などにより、近年著しい成長を遂げています。各国政府は、バイオ医薬品の製造と研究開発のために、バイオ医薬品企業への投資や助成金・資金提供などのイニシアチブをとっており、バイオ製造の持続可能な方法を開発するために協力している企業も複数あります。これらの要因は、バイオ医薬品メーカーにおけるバイオリアクターの採用拡大に寄与し、同セグメントの大きな市場シェアに貢献しています。

世界のバイオリアクター市場の地域別シナリオの詳細分析では、5つの主要地域（北米、欧州、アジア太平洋、中東・アフリカ、ラテンアメリカ）の詳細な定性的・定量的洞察を、各地域の主要国のカバレッジとともに提供しています。

2024年には、北米が世界のバイオリアクター市場で34%の最大シェアを占め、次いで欧州、アジア太平洋、ラテンアメリカ、中東・アフリカが続くと予想されています。北米の市場シェアが大きいのは、大手バイオ医薬品企業の存在、研究開発投資の高さ、バイオ医薬品の利用を促進するための政府・規制当局からの支援、バイオ医薬品企業による製造能力拡大の取り組みなどが背景にあります。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場洞察

• 概要
• 促進要因
  • バイオ医薬品工場の能力増強
  • 医薬品市場の成長
  • 医薬品研究開発費の増加
  • バイオシミラーの採用増加
  • 医薬品・バイオテクノロジー業界における使い捨て技術の採用拡大
• 抑制要因
  • バイオ医薬品の複雑な開発・製造プロセス
  • バイオ医薬品製造のための集中的な資本要件
• 機会
  • バイオリアクター技術の進歩
  • 個別化医薬品と細胞・遺伝子治療の採用増加
• 課題
  • シングルユース・バイオリアクターを使用したバイオ製造プロセスにおける抽出物・溶出物（E&L）のリスク
  • プロセスのスケールアップの限界
  • シングルユース・バイオリアクター設計の標準化の必要性
  • シングルユース・バイオリアクターの廃棄に関する環境への懸念
• 技術動向 / 市場動向
  • 商業生産における使い捨て処理装置の使用
  • 連続バイオプロセスへの注目の高まり
  • バイオプロセス4.0へのシフト
  • バイオプロセスにおけるAIの統合
• 規制シナリオ
• 価格分析
• 親市場分析
• ポーターのファイブフォース分析

第5章 世界のバイオリアクター市場：タイプ別

• 概要
• 連続攪拌タンク型バイオリアクター
• エアリフト・バイオリアクター
• 流動床バイオリアクター
• 充填床バイオリアクター
• 光バイオリアクター
  • 開放系バイオリアクター
  • クローズドシステムバイオリアクター
• メンブレンバイオリアクター

第6章 世界のバイオリアクター市場：バイオプロセス別

• 概要
• バッチ/フェドバッチバイオプロセシング
• 連続バイオプロセス

第7章 世界のバイオリアクター市場：細胞タイプ別

• 概要
• 哺乳類細胞
• 細菌細胞
• 酵母細胞
• その他の細胞タイプ

第8章 世界のバイオリアクター市場：用途別

• 概要
• 再利用可能バイオリアクター
  • ステンレス製
  • ガラス製
• シングルユースバイオリアクター

第9章 世界のバイオリアクター市場：スケール別

• 概要
• ラボスケールバイオリアクター（0.5L～10L）
• パイロットスケールバイオリアクター（10L～200L）
• 工業スケールバイオリアクター
  • 200L～500L
  • 500L～1000L
  • 1,500L以上

第10章 世界のバイオリアクター市場：用途別

• 概要
• 商業生産
  • モノクローナル抗体（mAb）生産
  • 細胞・遺伝子治療製造
  • ワクチン製造
  • 血漿分画
  • 組み換えタンパク質製造
• 開発、前臨床、臨床

第11章 世界のバイオリアクター市場：エンドユーザー別

• 概要
• バイオ医薬品メーカー
• 研究開発機関
• 製造受託機関

第12章 バイオリアクター市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • スイス
  • アイルランド
  • デンマーク
  • ベルギー
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ

第13章 競合分析

• 概要
• 主要成長戦略
• 競合ベンチマーキング
• 競合ダッシュボード
  • 市場リーダー
  • 差別化要因
  • 先行企業
  • 新興企業
• 市場シェア分析（2023年）

第14章 企業プロファイル（企業概要、財務概要、製品ポートフォリオ、戦略的展開）

• Thermo Fisher Scientific, Inc.
• METTLER TOLEDO
• Merck KGaA
• Eppendorf AG
• Sartorius AG
• Danaher Corporation
• Donaldson Company, Inc.
• BBI-Biotech GmbH
• Infors AG
• Pharsol Ltd.
• その他の企業

（注：上位5社のSWOT分析を提供します）

第15章 付録

LIST OF TABLES

• Table 1 Global Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 2 Global Continuous Stirred-tank Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 3 Global Airlift Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 4 Global Fluidized-bed Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 5 Global Packed-bed Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 6 Global Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 7 Global Photobioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 8 Global Open System Photobioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 9 Global Closed System Photobioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 10 Global Membrane Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 11 Global Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 12 Global Batch/Fed-batch Bioprocessing Market, by Country/Region, 2022-2031 (USD Million)
• Table 13 Global Continuous Bioprocessing Market, by Country/Region, 2022-2031 (USD Million)
• Table 14 Global Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 15 Global Bioreactors Market for Mammalian Cells, by Country/Region, 2022-2031 (USD Million)
• Table 16 Global Bioreactors Market for Bacterial Cells, by Country/Region, 2022-2031 (USD Million)
• Table 17 Global Bioreactors Market for Yeast Cells, by Country/Region, 2022-2031 (USD Million)
• Table 18 Global Bioreactors Market for Other Cells, by Country/Region, 2022-2031 (USD Million)
• Table 19 Global Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 20 Global Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 21 Global Reusable Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 22 Global Stainless Steel based Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 23 Global Glass-based Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 24 Global Single-use Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 25 Global Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 26 Global Lab Scale Bioreactors (0.5L-10L) Market, by Country/Region, 2022-2031 (USD Million)
• Table 27 Global Pilot Scale Bioreactors (10L-200L) Market, by Country/Region, 2022-2031 (USD Million)
• Table 28 Global Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 29 Global Industrial Scale Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 30 Global 200L-500L Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 31 Global 500L-1000L Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 32 Global Above 1,500L Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 33 Global Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 34 Global Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 35 Global Monoclonal Antibodies (mAb) Production Market, by Country/Region, 2022-2031 (USD Million)
• Table 36 Global Cell & Gene Therapy Production Market, by Country/Region, 2022-2031 (USD Million)
• Table 37 Global Vaccine Manufacturing Market, by Country/Region, 2022-2031 (USD Million)
• Table 38 Global Plasma Fractionation Market, by Country/Region, 2022-2031 (USD Million)
• Table 39 Global Recombinant Protein Production Market, by Country/Region, 2022-2031 (USD Million)
• Table 40 Global Bioreactors Market for Developmental, Preclinical & Clinical Applications, by Country/Region, 2022-2031 (USD Million)
• Table 41 Global Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 42 Global Bioreactors Market for Biopharmaceutical Manufacturers, by Country/Region, 2022-2031 (USD Million)
• Table 43 Global Bioreactors Market for Research & Development Organizations, by Country/Region, 2022-2031 (USD Million)
• Table 44 Global Bioreactors Market for Contract Manufacturing Organizations, by Country/Region, 2022-2031 (USD Million)
• Table 45 Global Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 46 North America: Bioreactors Market, by Country, 2022-2031 (USD Million)
• Table 47 North America: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 48 North America: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 49 North America: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 50 North America: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 51 North America: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 52 North America: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 53 North America: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 54 North America: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 55 North America: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 56 North America: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 57 North America: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 58 U.S.: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 59 U.S.: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 60 U.S.: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 61 U.S.: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 62 U.S.: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 63 U.S.: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 64 U.S.: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 65 U.S.: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 66 U.S.: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 67 U.S.: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 68 U.S.: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 69 Canada: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 70 Canada: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 71 Canada: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 72 Canada: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 73 Canada: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 74 Canada: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 75 Canada: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 76 Canada: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 77 Canada: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 78 Canada: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 79 Canada: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 80 Europe: Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 81 Europe: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 82 Europe: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 83 Europe: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 84 Europe: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 85 Europe: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 86 Europe: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 87 Europe: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 88 Europe: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 89 Europe: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 90 Europe: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 91 Europe: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 92 Germany: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 93 Germany: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 94 Germany: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 95 Germany: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 96 Germany: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 97 Germany: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 98 Germany: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 99 Germany: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 100 Germany: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 101 Germany: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 102 Germany: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 103 France: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 104 France: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 105 France: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 106 France: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 107 France: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 108 France: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 109 France: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 110 France: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 111 France: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 112 France: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 113 France: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 114 U.K.: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 115 U.K.: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 116 U.K.: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 117 U.K.: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 118 U.K.: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 119 U.K.: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 120 U.K.: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 121 U.K.: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 122 U.K.: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 123 U.K.: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 124 U.K.: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 125 Italy: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 126 Italy: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 127 Italy: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 128 Italy: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 129 Italy: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 130 Italy: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 131 Italy: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 132 Italy: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 133 Italy: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 134 Italy: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 135 Italy: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 136 Spain: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 137 Spain: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 138 Spain: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 139 Spain: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 140 Spain: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 141 Spain: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 142 Spain: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 143 Spain: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 144 Spain: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 145 Spain: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 146 Spain: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 147 Switzerland: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 148 Switzerland: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 149 Switzerland: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 150 Switzerland: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 151 Switzerland: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 152 Switzerland: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 153 Switzerland: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 154 Switzerland: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 155 Switzerland: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 156 Switzerland: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 157 Switzerland: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 158 Ireland: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 159 Ireland: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 160 Ireland: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 161 Ireland: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 162 Ireland: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 163 Ireland: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 164 Ireland: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 165 Ireland: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 166 Ireland: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 167 Ireland: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 168 Ireland: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 169 Denmark: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 170 Denmark: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 171 Denmark: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 172 Denmark: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 173 Denmark: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 174 Denmark: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 175 Denmark: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 176 Denmark: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 177 Denmark: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 178 Denmark: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 179 Denmark: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 180 Belgium: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 181 Belgium: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 182 Belgium: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 183 Belgium: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 184 Belgium: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 185 Belgium: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 186 Belgium: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 187 Belgium: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 188 Belgium: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 189 Belgium: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 190 Belgium: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 191 Rest of Europe: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 192 Rest of Europe: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 193 Rest of Europe: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 194 Rest of Europe: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 195 Rest of Europe: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 196 Rest of Europe: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 197 Rest of Europe: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 198 Rest of Europe: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 199 Rest of Europe: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 200 Rest of Europe: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 201 Rest of Europe: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 202 Asia-Pacific: Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 203 Asia-Pacific: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 204 Asia-Pacific: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 205 Asia-Pacific: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 206 Asia-Pacific: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 207 Asia-Pacific: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 208 Asia-Pacific: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 209 Asia-Pacific: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 210 Asia-Pacific: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 211 Asia-Pacific: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 212 Asia-Pacific: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 213 Asia-Pacific: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 214 Japan: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 215 Japan: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 216 Japan: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 217 Japan: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 218 Japan: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 219 Japan: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 220 Japan: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 221 Japan: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 222 Japan: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 223 Japan: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 224 Japan: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 225 China: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 226 China: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 227 China: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 228 China: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 229 China: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 230 China: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 231 China: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 232 China: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 233 China: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 234 China: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 235 China: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 236 India: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 237 India: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 238 India: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 239 India: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 240 India: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 241 India: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 242 India: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 243 India: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 244 India: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 245 India: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 246 India: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 247 South Korea: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 248 South Korea: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 249 South Korea: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 250 South Korea: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 251 South Korea: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 252 South Korea: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 253 South Korea: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 254 South Korea: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 255 South Korea: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 256 South Korea: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 257 South Korea: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 258 Rest of Asia-Pacific: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 259 Rest of Asia-Pacific: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 260 Rest of Asia-Pacific: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 261 Rest of Asia-Pacific: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 262 Rest of Asia-Pacific: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 263 Rest of Asia-Pacific: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 264 Rest of Asia-Pacific: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 265 Rest of Asia-Pacific: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 266 Rest of Asia-Pacific: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 267 Rest of Asia-Pacific: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 268 Rest of Asia-Pacific: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 269 Latin America: Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 270 Latin America: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 271 Latin America: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 272 Latin America: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 273 Latin America: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 274 Latin America: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 275 Latin America: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 276 Latin America: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 277 Latin America: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 278 Latin America: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 279 Latin America: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 280 Latin America: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 281 Brazil: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 282 Brazil: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 283 Brazil: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 284 Brazil: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 285 Brazil: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 286 Brazil: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 287 Brazil: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 288 Brazil: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 289 Brazil: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 290 Brazil: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 291 Brazil: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 292 Mexico: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 293 Mexico: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 294 Mexico: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 295 Mexico: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 296 Mexico: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 297 Mexico: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 298 Mexico: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 299 Mexico: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 300 Mexico: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 301 Mexico: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 302 Mexico: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 303 Rest of Latin America: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 304 Rest of Latin America: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 305 Rest of Latin America: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 306 Rest of Latin America: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 307 Rest of Latin America: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 308 Rest of Latin America: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 309 Rest of Latin America: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 310 Rest of Latin America: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 311 Rest of Latin America: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 312 Rest of Latin America: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 313 Rest of Latin America: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 314 Middle East & Africa: Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
• Table 315 Middle East & Africa: Bioreactors Market, by Type, 2022-2031 (USD Million)
• Table 316 Middle East & Africa: Photobioreactors Market, by Type, 2022-2031 (USD Million)
• Table 317 Middle East & Africa: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
• Table 318 Middle East & Africa: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
• Table 319 Middle East & Africa: Bioreactors Market, by Usability, 2022-2031 (USD Million)
• Table 320 Middle East & Africa: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
• Table 321 Middle East & Africa: Bioreactors Market, by Scale, 2022-2031 (USD Million)
• Table 322 Middle East & Africa: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
• Table 323 Middle East & Africa: Bioreactors Market, by Application, 2022-2031 (USD Million)
• Table 324 Middle East & Africa: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
• Table 325 Middle East & Africa: Bioreactors Market, by End User, 2022-2031 (USD Million)
• Table 326 Recent Developments, by Company, 2020-2024

LIST OF FIGURES

• Figure 1 Research Process
• Figure 2 Key Secondary Sources
• Figure 3 Primary Research Techniques
• Figure 4 Key Executives Interviewed
• Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
• Figure 6 Market Size Estimation
• Figure 7 Global Bioreactors Market, by Type, 2024 VS. 2031 (USD Million)
• Figure 8 Global Bioreactors Market, by Bioprocess, 2024 VS. 2031 (USD Million)
• Figure 9 Global Bioreactors Market, by Cell Type, 2024 VS. 2031 (USD Million)
• Figure 10 Global Bioreactors Market, by Usability, 2024 VS. 2031 (USD Million)
• Figure 11 Global Bioreactors Market, by Scale, 2024 VS. 2031 (USD Million)
• Figure 12 Global Bioreactors Market, by Application, 2024 VS. 2031 (USD Million)
• Figure 13 Global Bioreactors Market, by End User, 2024 VS. 2031 (USD Million)
• Figure 14 Global Bioreactors Market, by Geography
• Figure 15 Global Bioreactors Market, by Product, 2024 VS. 2031 (USD Million)
• Figure 16 Global Bioreactors Market, by Bioprocess, 2024 VS. 2031 (USD Million)
• Figure 17 Global Bioreactors Market, by Cell Type, 2024 VS. 2031 (USD Million)
• Figure 18 Global Bioreactors Market, by Usability, 2024 VS. 2031 (USD Million)
• Figure 19 Global Bioreactors Market, by Scale, 2024 VS. 2031 (USD Million)
• Figure 20 Global Bioreactors Market, by Application, 2024 VS. 2031 (USD Million)
• Figure 21 Global Bioreactors Market, by End User, 2024 VS. 2031 (USD Million)
• Figure 22 Global Bioreactors Market, by Geography, 2024 VS. 2031 (USD Million)
• Figure 23 North America: Bioreactors Market Snapshot
• Figure 24 Europe: Bioreactors Market Snapshot
• Figure 25 Asia-Pacific: Bioreactors Market Snapshot
• Figure 26 Latin America: Bioreactors Market Snapshot
• Figure 27 Key Growth Strategies Adopted by Leading Players, 2020-2024
• Figure 28 Global Bioreactors Market: Competitive Benchmarking, by Product
• Figure 29 Global Bioreactors Market: Competitive Dashboard
• Figure 30 Global Bioreactors Market: Market Share Analysis/Market Ranking (2024)
• Figure 31 Thermo Fisher Scientific, Inc.: Financial Overview (2024)
• Figure 32 Merck KGaA: Financial Overview (2024)
• Figure 33 Eppendorf AG: Financial Overview (2022)
• Figure 34 Sartorius AG: Financial Overview (2022)
• Figure 35 Danaher Corporation: Financial Overview (2024)
• Figure 36 Donaldson Company, Inc.: Financial Overview (2024)

Bioreactors Market Size, Share, Forecast, & Trends Analysis by Type (continuous Stirred Tank, Photobioreactor) Bioprocess (Batch, Continuous) Usability (Reusable, Single-use) Scale (Pilot, Industrial) Cell Type, Application, User-Global Forecast to 2031.

The global bioreactors market is projected to reach $39.96 billion by 2031, at a CAGR of 10.1% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides insights into the key drivers, restraints, opportunities, and challenges of the bioreactors market. The growth of this market is driven by the expansion of biopharmaceutical plants, the growth of the pharmaceuticals sector, increased R&D expenditures in pharmaceuticals, the rising adoption of biosimilars, and the growing adoption of disposable technologies in the pharmaceutical and biotechnology sectors. However, the complex development & manufacturing processes of biopharmaceuticals and high capital requirements for biopharmaceutical production restrain the market's growth.

Moreover, advancements in bioreactor technologies and the rising adoption of personalized medicines and cell & gene therapies are expected to create market growth opportunities. However, risks associated with extractables and leachables (E&L) in biomanufacturing processes using single-use bioreactors, limitations in scaling up biopharmaceutical processes, the need to standardize designs for single-use bioreactors, and environmental concerns related to the disposal of single-use bioreactors are some of the challenges impacting the market's growth.

Based on product, in 2024, the continuous stirred-tank bioreactors segment is expected to account for the largest share of 31% of the bioreactors market. This segment's large market share can be attributed to technological advancements in continuous stirred-tank bioreactors and their capability to handle higher concentrations of reactants due to their superior heat transfer properties compared to other bioreactors. Additionally, market players are enhancing bioreactor designs to integrate seamlessly with existing flow systems. For instance, in October 2024, Vapourtec Ltd. (U.K.) launched a continuous stirred-tank bioreactor designed for continuous process synthesis, specifically designed to work alongside existing flow-chemistry systems.

Based on bioprocess, in 2024, the batch/fed-batch segment is expected to account for the largest share of the bioreactors market. This segment's large market share can be attributed to the advantages of batch/fed-batch bioprocessing, including high productivity, simplified management of bioprocesses, and reduced risks of contamination. The duration of batch processing is ideal for rapid experimentation and accelerates upstream processes, thereby enhancing overall productivity.

Based on cell type, in 2024, the mammalian cells segment is expected to account for the largest share of the bioreactors market. This segment's large market share can be attributed to the increasing focus on commercial and research bioproduction for complex biomolecules such as monoclonal antibodies and therapeutic proteins. Additionally, the growth in clinical research involving mammalian cells has led to their widespread adoption in single-use bioreactors.

Based on usability, in 2024, the reusable bioreactors segment is expected to account for the larger share of the bioreactors market. This segment's large market share can be attributed to the increase in large-scale manufacturing, where reusable bioreactors are increasingly adopted due to their cost efficiency and suitability for handling high volumes of production. Moreover, the high costs and regulatory restrictions associated with waste disposal drive the increased adoption of reusable bioreactors.

Based on scale, the pilot scale bioreactors (10L-200L) segment is slated to register the highest CAGR in the market. Pilot scale bioreactors are systems that are between the capacity of 10L-200L and include multiple variations and customizations. They find extensive application in the food, pharmaceutical, and cosmetics industries, primarily for testing and refining bioprocesses before full-scale production. The increasing demand for commercial bioproduction drives the adoption of pilot scale bioprocessing, as these bioreactors are crucial in assessing efficiency, scalability, and performance under conditions closely resembling industrial settings.

Based on automation, in 2024, the automated bioreactors segment is expected to account for the larger share of the market. This segment's large market share can be attributed to the benefits offered by automated bioreactors, including enhanced process quality, reduced errors, optimized process control, and cost savings. Automated bioreactors contribute to improved quality and productivity through real-time monitoring and data-rich quality control. They streamline procedures and experiments, ensuring swift detection of deviations in processes.

Based on application, in 2024, the commercial production segment is expected to account for the larger share of the bioreactors market. The commercial production consists of monoclonal antibodies (mAb) production, cell & gene therapy production, vaccine manufacturing, plasma fractionation, and recombinant protein production. This segment's large market share can be attributed to the growing adoption of biopharmaceuticals, favorable regulatory reforms aimed at promoting the adoption of biosimilars, and rising investments in developing gene therapies.

Based on end user, in 2024, the biopharmaceutical manufacturers segment is expected to account for the largest share of the market. Biopharmaceutical companies have witnessed significant growth in recent years due to the increasing demand for biopharmaceuticals, growing incidence of chronic diseases, rising R&D expenditure by pharmaceutical & biotechnology companies, and recent launches of biologics for chronic & rare diseases. Governments of various countries are taking initiatives by making investments and providing grants & funds to biopharmaceutical companies for the manufacture and R&D of biopharmaceuticals, along with several companies that are collaborating to develop sustainable methods for biomanufacturing. These factors contribute to the increased adoption of bioreactors among biopharmaceutical manufacturers, contributing to the segment's large market share.

An in-depth analysis of the geographical scenario of the global bioreactors market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region.

In 2024, North America is expected to account for the largest share of 34% of the global bioreactors market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America's significant market share can be attributed to the presence of large biopharmaceutical companies, high R&D investments, support from government and regulatory authorities to promote the use of biopharmaceuticals, and initiatives by biopharmaceutical companies to expand their manufacturing capacities.

The key players operating in the global bioreactors market are Thermo Fisher Scientific, Inc. (U.S.), METTLER TOLEDO (U.S.), Merck KGaA (Germany), Eppendorf AG (Germany), Sartorius AG (Germany), Danaher Corporation (U.S.), Donaldson Company, Inc. (U.S.), BBI-Biotech GmbH (Germany), Infors AG (Switzerland), and Pharsol Ltd. (Slovenia).

Scope of the Report:

Bioreactors Market-by Product

• Continuous Stirred Tank Bioreactors
• Airlift Bioreactors
• Fluidized-bed Bioreactors
• Packed-bed Bioreactors
• Photobioreactors
  • Open System Photobioreactors
  • Closed System Photobioreactors
• Membrane Bioreactors

Bioreactors Market-by Bioprocess

• Batch/Fed-batch Bioprocessing
• Continuous Bioprocessing

Bioreactors Market-by Cell Type

• Mammalian Cells
• Bacterial Cells
• Yeast Cells
• Other Cell Types

(Other cell types include plant cells and insect cells)

Bioreactors Market-by Usability

• Reusable Bioreactors
  • Reusable Bioreactors by Material
• Stainless Steel
• Glass
• Single-use Bioreactors

Bioreactors Market-by Scale

• Lab Scale Bioreactors (0.5L-10L)
• Pilot Scale Bioreactors (10L-200L)
• Industrial Scale Bioreactors
  • 200L-500L
  • 500L-1000L
  • Above 1,500L

Bioreactors Market-by Automation

• Manual/Semi-automated Bioreactors
• Automated Bioreactors

Bioreactors Market-by Application

• Commercial Production
  • Monoclonal Antibodies (mAb) Production
  • Cell & Gene Therapy Production
  • Vaccine Manufacturing
  • Plasma Fractionation
  • Recombinant Protein Production
• Developmental, Preclinical, & Clinical

Bioreactors Market-by End User

• Biopharmaceutical Manufacturers
• Research & Development Organizations
• Contract Manufacturing Organizations

Bioreactors Market-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Switzerland
  • Ireland
  • Denmark
  • Belgium
  • Rest of Europe (RoE)
• Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Rest of APAC (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLATAM)
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection and Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
• 2.3. Market Sizing and Forecast
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumption for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Capacity Expansion of Biopharmaceutical Plants
  • 4.2.2. Growing Pharmaceutical Market
  • 4.2.3. Rising Pharmaceutical R&D Expenditures
  • 4.2.4. Rising Adoption of Biosimilars
  • 4.2.5. Growing Adoption of Disposable Technologies in the Pharmaceutical and Biotechnology Industries
• 4.3. Restraints
  • 4.3.1. Complex Development and Manufacturing Process of Biopharmaceuticals
  • 4.3.2. Intensive Capital Requirements for Biopharmaceuticals Production
• 4.4. Opportunities
  • 4.4.1. Technological Advancements in Bioreactor Technologies
  • 4.4.2. Rising Adoption of Personalized Medicines and Cell & Gene Therapies
• 4.5. Challenges
  • 4.5.1. Risk of Extractables and Leachables (E&L) in Biomanufacturing Processes Using Single-use Bioreactors
  • 4.5.2. Process Scale-up Limitations
  • 4.5.3. Need to Standardize Single-use Bioreactor Designs
  • 4.5.4. Environmental Concerns Related to the Disposal of Single-use Bioreactors
• 4.6. Technology Trends/Market Trends
  • 4.6.1. Use of Disposable Processing Equipment for Commercial Production
  • 4.6.2. Rising Focus on Continuous Bioprocessing
  • 4.6.3. Shift Towards Bioprocessing 4.0
  • 4.6.4. Integration of AI in Bioprocessing
• 4.7. Regulatory Scenario
• 4.8. Pricing Analysis
• 4.9. Parent Market Analysis
• 4.10 Porter's Five Forces Analysis

5. Global Bioreactors Market-by Type

• 5.1. Overview
• 5.2. Continuous Stirred-tank Bioreactors
• 5.3. Airlift Bioreactors
• 5.4. Fluidized-bed Bioreactors
• 5.5. Packed-bed Bioreactors
• 5.6. Photobioreactors
  • 5.6.1. Open System Bioreactors
  • 5.6.2. Closed System Bioreactors
• 5.7. Membrane Bioreactors

6. Global Bioreactors Market-by Bioprocess

• 6.1. Overview
• 6.2. Batch/Fed-batch Bioprocessing
• 6.3. Continuous Bioprocessing

7. Global Bioreactors Market-by Cell Type

• 7.1. Overview
• 7.2. Mammalian Cells
• 7.3. Bacterial Cells
• 7.4. Yeast Cells
• 7.5. Other Cell Types

8. Global Bioreactors Market-by Usability

• 8.1. Overview
• 8.2. Reusable Bioreactors
  • 8.2.1. Stainless Steel
  • 8.2.2. Glass
• 8.3. Single-use Bioreactors

9. Global Bioreactors Market-by Scale

• 9.1. Overview
• 9.2. Lab Scale Bioreactors (0.5L-10L)
• 9.3. Pilot Scale Bioreactors (10L-200L)
• 9.4. Industrial Scale Bioreactors
  • 9.4.1. 200L-500L
  • 9.4.2. 500L-1000L
  • 9.4.3. Above 1,500L

10. Global Bioreactors Market-by Application

• 10.1. Overview
• 10.2. Commercial Production
  • 10.2.1. Monoclonal Antibodies (mAb) Production
  • 10.2.2. Cell & Gene Therapy Production
  • 10.2.3. Vaccine Manufacturing
  • 10.2.4. Plasma Fractionation
  • 10.2.5. Recombinant Protein Production
• 10.3. Development, Preclinical, & Clinical

11. Global Bioreactors Market-by End User

• 11.1. Overview
• 11.2. Biopharmaceutical Manufacturers
• 11.3. Research & Development Organizations
• 11.4. Contract Manufacturing Organizations

12. Bioreactors Market-by Geography

• 12.1. Overview
• 12.2. North America
  • 12.2.1. U.S.
  • 12.2.2. Canada
• 12.3. Europe
  • 12.3.1. Germany
  • 12.3.2. France
  • 12.3.3. U.K.
  • 12.3.4. Italy
  • 12.3.5. Spain
  • 12.3.6. Switzerland
  • 12.3.7. Ireland
  • 12.3.8. Denmark
  • 12.3.9. Belgium
  • 12.3.10. Rest of Europe
• 12.4. Asia-Pacific
  • 12.4.1. Japan
  • 12.4.2. China
  • 12.4.3. India
  • 12.4.4. South Korea
  • 12.4.5. Rest of Asia Pacific
• 12.5. Latin America
  • 12.5.1. Brazil
  • 12.5.2. Mexico
  • 12.5.3. Rest of Latin America
• 12.6. Middle East & Africa

13. Competition Analysis

• 13.1. Overview
• 13.2. Key Growth Strategies
• 13.3. Competitive Benchmarking
• 13.4. Competitive Dashboard
  • 13.4.1. Market Leaders
  • 13.4.2. Market Differentiators
  • 13.4.3. Vanguards
  • 13.4.4. Emerging Companies
• 13.5. Market Share Analysis (2023)

14. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

• 14.1. Thermo Fisher Scientific, Inc.
• 14.2. METTLER TOLEDO
• 14.3. Merck KGaA
• 14.4. Eppendorf AG
• 14.5. Sartorius AG
• 14.6. Danaher Corporation
• 14.7. Donaldson Company, Inc.
• 14.8. BBI-Biotech GmbH
• 14.9. Infors AG
• 14.10. Pharsol Ltd.
• 14.11. Other Companies

(Note: SWOT analysis of the top 5 companies will be provided.)

15. Appendix

• 15.1. Available Customization
• 15.2. Related Reports